On September 19, 2024, IBO’s average trading volume was 111.84K shares.
IBO) stock’s latest price update
The stock of Impact BioMedical, Inc. (AMEX: IBO) has increased by 10.88 when compared to last closing price of 2.39. globenewswire.com reported 2024-09-17 that NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced the closing of its previously announced initial public offering of 1,500,000 shares of its common stock at a public offering price of $3.00 per share. The shares began trading on the NYSE American Market on September 16, 2024, under the ticker symbol “IBO”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
IBO’s Market Performance
The simple moving average for the last 20 days is 7.43% for IBO stock, with a simple moving average of 7.43% for the last 200 days.
IBO Trading at 7.43% from the 50-Day Moving Average
After a stumble in the market that brought IBO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.67% of loss for the given period.
Over the last 50 days, in opposition, the stock is trading unchanged at present.
During the last 5 trading sessions, IBO remain unchanged, which changed the moving average for the period of 200-days by +2.64% in comparison to the 20-day moving average, which settled at $24.84. In addition, Impact BioMedical, Inc. saw -1.12% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IBO starting from DSS, INC., who purchase 50,000 shares at the price of $2.69 back on Sep 16 ’24. After this action, DSS, INC. now owns 50,000 shares of Impact BioMedical, Inc., valued at $134,500 using the latest closing price.
DSS, INC., the 10% Owner of Impact BioMedical, Inc., purchase 7,800 shares at $2.40 during a trade that took place back on Sep 17 ’24, which means that DSS, INC. is holding 57,800 shares at $18,720 based on the most recent closing price.
Conclusion
To wrap up, the performance of Impact BioMedical, Inc. (IBO) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
